Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
about
Sex hormones selectively impact the endocervical mucosal microenvironment: implications for HIV transmissionHormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysisHormonal contraception for women exposed to HIV infectionIncident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysisPreconception and contraceptive care for women living with HIVContraceptive methods and risk of HIV acquisition or female-to-male transmissionThe complexity of contraceptives: understanding their impact on genital immune cells and vaginal microbiota.Factors Driving the HIV Epidemic in Southern Africa.Clinical parameters essential to methodology and interpretation of mucosal responsesGreentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice.Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studiesAssessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approachesInjectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk?The injectable-only contraceptive medroxyprogesterone acetate, unlike norethisterone acetate and progesterone, regulates inflammatory genes in endocervical cells via the glucocorticoid receptor.The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities.Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users.Bridging the gap between preclinical and clinical microbicide trials: blind evaluation of candidate gels in murine models of efficacy and safety.The effects of reproductive hormones on the physical properties of cervicovaginal fluid.Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe.Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent mannerChanges in genital tract immune cell populations after initiation of intrauterine contraception.Hormonal contraception and area of cervical ectopy: a longitudinal assessment.Hormonal contraception and HIV-1 transmission.Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraceptionThe progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor.Sexual and reproductive health: progress and outstanding needs.A combined oral contraceptive affects mucosal SHIV susceptibility factors in a pigtail macaque (Macaca nemestrina) model.The ring plus project: safety and acceptability of vaginal rings that protect women from unintended pregnancy.Interventions to prevent sexually transmitted infections, including HIV infection.What works to meet the sexual and reproductive health needs of women living with HIV/AIDS.Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.Medroxyprogesterone acetate impairs human dendritic cell activation and function.Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.The effect of menopause on the innate antiviral activity of cervicovaginal lavage.Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions.The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
P2860
Q21090622-DD3F46FB-3A53-43FC-9C4D-3BD016601713Q21144588-985FB402-2169-4CD5-91A7-4CCAFCB7675AQ24194597-77FD9627-0907-435E-B3AC-6716275A3207Q27010727-85B3A9EE-EDF4-4CF4-9FA2-3067C0BE6DFAQ27012918-C3190B94-D76F-45CF-BD0F-4955D92ECE2DQ27027323-66B3F567-7D8A-42DD-89B4-990B2EB8B282Q27692596-25B7D2B4-8CE0-45DB-9F48-9F6EA3C385E7Q30387557-F8FC02A6-4D13-4585-8C7E-CC610123914AQ30398452-38A45854-33F3-46E8-B206-29B097F81F29Q30416473-E2CED65B-DEAE-49FA-BDC6-6F784D73111CQ30447923-990FCF72-AE5D-400D-8D4C-9609204FB87CQ30660068-215D1338-7FD3-4BDE-B033-BD7469774873Q30671120-741AD8A0-5EFE-4BA2-B8FE-5912CF14655DQ30823365-60EF47A2-D073-4EF0-B7AA-87EFF507508FQ31014284-3B248655-7ECD-47E3-A442-A752BE8275D4Q33552342-1B7EC421-6090-4A09-A5BF-CC2AAAE97FA0Q33631772-EFE10715-7760-4FA5-BDB6-924F69BFC59CQ33662836-3B4266E8-3BE4-4333-AB9E-44412E98FBD7Q33763511-5BD3209F-86F2-4367-AE82-7C8E6A45CCBEQ34023815-5B75772E-B56F-4B09-8782-8BD419717FAAQ34078011-A4B1486D-7C3A-4907-9F5C-80FD7417B525Q34111702-8125C83A-16F7-4261-AFFF-7DCB2231DCD6Q34173869-8DBE468C-DC40-4188-92C6-571A652CAA5DQ34467518-F825A806-5478-4418-9EF8-247160B3A05BQ34506212-C97612AF-9FB4-42A4-94A5-68F292401C0AQ34675983-4055C7FD-E21A-4D10-B1BB-8E99F1F60E55Q34679705-409BCDDF-F317-4EC6-B7A6-341738163F1BQ34700364-2C6CBC19-5ED2-444C-ABC4-280CFE6C02DEQ34712821-B4C3BF17-7E74-47B5-9DE2-0910A0C82A45Q35052560-9AC25584-369D-41C0-A5CD-46DD5C47BB80Q35164046-6516ED5F-906E-4A05-9311-13D5ACCEFD3BQ35495892-D13CA36D-03D8-40AF-9445-2D6F09C4FD11Q35542152-DB950384-5866-4C48-8ED2-104282A561E4Q35642606-E6B07378-7B3A-4E25-8182-CEB281151B00Q35699938-C651906C-92EF-49C6-9101-CAFFE11DD62DQ35784803-9175A26F-C525-4890-A024-BDCF17DEF612Q35814961-C6B94141-C7C4-4869-80DD-1FAEC00423C1Q35901184-94F4E859-A488-4C56-8DF0-233243D8CEF0Q36001388-08F07D02-87DB-4506-B5C1-C13F99FF3BDFQ36017351-6DD75D0B-2E05-4DF8-8E3C-5C9BA50B5581
P2860
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@ast
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@en
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@nl
type
label
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@ast
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@en
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@nl
prefLabel
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@ast
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@en
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@nl
P2093
P2860
P1433
P1476
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling
@en
P2093
Barbra A Richardson
Charles S Morrison
Cynthia Kwok
Josaphat Byamugisha
Nancy Padian
Pai-Lien Chen
Robert A Salata
Roy Mugerwa
P2860
P304
P356
10.1097/QAD.0B013E32833A2537
P407
P577
2010-07-01T00:00:00Z